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Volume 54, Number 4 Abstracts 1227Introduction and objectives: Few options exist for treating patients with
massive inferior vena cava (IVC) and iliofemoral deep vein thrombosis (DVT)
and a contraindication to thrombolysis.Wepresent five patientswhounderwent
IVC/iliac mechanical venous thrombectomy using a novel intravascular device.
Methods:During a 6-month period, five patients underwent mechan-
ical aspiration thrombectomy of IVC/iliac venous occlusion using the
Vortex Angiovac system. A 22F cannula was placed into the iliac venous
system via bilateral femoral cutdowns. The cannula was connected to a
venovenous bypass circuit, and thrombus was trapped in a separate filter
(Fig). Anticoagulated blood was returned to the patient via a right internal
jugular venous cannula. Open thrombectomy was performed of the bilateral
lower extremity veins.
Results: Five patients presented with acute (3 months) IVC throm-
bosis, manifested by phlegmasia in three or debilitating lower extremity
swelling in two. All patients had a contraindication to thrombolytic therapy.
Four patients had documented hypercoagulable states and a previously
placed IVC filter. IVC thrombectomy was successful in all five patients.
Intravascular ultrasound (IVUS) identified residual stenosis in four patients,
which were successfully treated with Wallstents. Mean procedure time was
389 minutes. Patients were discharged at an average of 8.5 days postopera-
tively on full anticoagulation. There were no deaths. Lower extremity edema
significantly improved in all patients. Follow-up computed tomography scan
at a mean of 72 days showed continued patency of the IVC in all patients.
Conclusions: The Vortex AngioVac provides a safe and effective
alternative method for treating massive acute (3 months) IVC thrombosis
in patients with a contraindication to thrombolysis.
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Introduction and objectives: Strict glucose control in patients undergo-
ing coronary bypass grafting has been shown to decrease infectious complica-
tions, arrhythmias, and death. Our objective was to determine if strict glucose
control reduced morbidity after lower extremity bypass (LEB).
Methods:Aprospective pilot study at a single institutionwithin theVascular
Study Group of New England was conducted from January 2009 to December
2010. Diabetic and nondiabetic patients undergoing LEB received an insulin
infusion for 3 days after surgery, with titration of blood glucose to 80 to 120
mg/dL. The study group of 104 patients was compared with a historic control
group of 189 patients from the preceding 2 years. Fisher exact test, t tests, and 2,
and logistic regression analyses were used to compare in-hospital morbidity. Strati-
fied analyses were conducted to determine if findings differed by the presence or
absence of diabetes.
Results: There was no difference between the insulin infusion group
and historical control group with regard to graft infection, myocardial
infarction, dysrhythmias, primary patency at discharge, or mortality rate.
Patients in the intravenous insulin group had significantly fewer wound
infections (4% vs 11%; odds ratio [OR], 0.32; 95% confidence interval [CI],
0.11-0.96; P  .047). This association was strengthened after adjusting for
potentially confounding baseline differences in gender, body mass index,
and smoking status (adjusted OR, 0.22; 95% CI, 0.06-0.84; P .03). When
Fig. Thrombus was trapped in a separate filter.stratified by presence of diabetes, wound infections were decreased in the
insulin infusion group (0 of 44 [0%] vs 9 of 90 [10%], P  .03.) There was
3
Ao statistically significant difference in wound infection between nondiabetic
ndividuals in the insulin infusion group and the control group.
Conclusions: Strict glucose control with a postoperative insulin infu-
ion protocol significantly decreased the incidence of postoperative wound
nfection in all diabetic individuals undergoing LEB. These previously
nreported findings from this single-institution prospective study warrant
urther multi-institutional investigation.
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Introduction and objectives: Packed red blood cell transfusion has
een postulated to increase morbidity andmortality after cardiac and general
urgical operations, but its effects after lower extremity bypass (LEB) have
ot been studied extensively. Most studies have focused on the perioperative
eriod, but long-term effects of transfusion have not been elucidated.
Methods: Using the Vascular Study Group of New England database
2003-2010), we examined 2582 consecutive infrainguinal LEB procedures
erformed by 71 surgeons at academic and community hospitals on patients
ith claudication and critical limb ischemia (CLI). Perioperative transfusionwas
ategorized as 0 units, 1 to 2 units, and 3 units. Patients who received 3
nits were case-matched for age, coronary artery disease, diabetes, and urgency
f revascularization with patients who received 1 to 2 or 0 units. Primary end
ointswere perioperative death, surgical site infection (SSI), andgraft patency at
ischarge, as well as mortality, SSI, and graft patency at 1 year.
Results: In the case-matched sample, 514 LEB patients (63%) received 0
nits, 194 (23.8%) received 1 to 2 units, and 108 (13.2%) received3 units of
acked red blood cells. Transfusion was associated with significantly higher
erioperative SSI and return to the operating room and with a significantly
ower discharge patency rate (Table). At 1 year, no significant differences existed
n mortality, SSI, or graft patency. In multivariate analysis, after controlling for
ndication of CLI vs claudication, transfusion was still associated with increased
erioperative SSI (P .006) and graft failure at discharge (P .0001).
Conclusions: Perioperative transfusion in patients undergoing LEB is
ssociated with increased SSI and perioperative graft failure. From this observa-
ional study, it appears transfusion does not have significant long-term conse-
uences, but its detrimental effects in the perioperative periodmust be weighed
arefully against the presumed benefits of blood replacement.
able. Patient characteristics and outcomes of transfusion
Characteristica
0 units 1-2 units 3 units
P(n 514) (n 194) (n 108)
Age, mean  SD,
years
73.4  10.7 73.3  11.1 74.6  10.8 .52
Proportion with
Critical limb
ischemia
410 (79.8) 176 (90.7) 100 (92.6) .0001
Diabetes mellitus 364 (70.8) 142 (73.2) 78 (72.2) .81
Coronary artery
disease
259 (50.4) 96 (49.5) 53 (49.1) .97
Great saphenous
vein
339 (66) 121 (62.4) 65 (60.2) .36
Perioperative SSI 20 (3.9) 15 (7.7) 16 (14.8) .0001
Graft patency at
discharge
487 (96.1) 178 (91.8) 89 (84) .0001
1-year outcomes
Mortality 59 (14.5) 28 (18.7) 17 (23.3) .12
SSI 22 (7.9) 14 (15.2) 4 (10.3) .12
Graft patency 232 (70.3) 85 (72.6) 32 (61.5) .34
D, Standard deviation;SSI, Surgical site infection
Data are shown as number (%) unless indicated otherwise.
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Introduction and objectives: Using an amortized cost model, we
rospectively evaluated the long-term costs associated with all initial and
einterventions of lower extremity endovascular revascularization (ER)
nd surgical revascularization (SR) for femoropopliteal occlusive disease.
Methods: Since 2004, 183 patients with femoropopliteal occlusive
isease had ER (85 [46%]) or SR (98 [54%]) for claudication (44% ER vs
6% SR, P NS) or chronic limb ischemia (56% ER vs 64% SR, P NS).
n amortized cost model that included patency data end points and all
